Antoinette de Jong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antoinette de Jong has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Bart de Keizer
Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands
2 shared publications Inge Ludwig
Bernhove Hosp, Dept Internal Med, Uden, Netherlands
2 shared publicationsJaap Stoker
Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
2 shared publicationsMarie José Kersten
Univ Amsterdam, Acad Med Ctr, Dept Hematol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
2 shared publicationsRob Fijnheer
Meander Med Ctr, Dept Hematol, Amersfoort, Netherlands
2 shared publicationsRutger A.J. Nievelstein
Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications
Latest Publications
- 13 April 2016
- Published by Wiley in American Journal of Hematology
- Vol. 91 (6) , 649-650
89Zr-rituximab PET/CT to detect neurolymphomatosis
- 13 April 2016
- Published by Wiley in American Journal of Hematology
- Vol. 91 (6) , 649-650
89Zr-rituximab PET/CT to detect neurolymphomatosis
- 1 January 2016
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 40 (2) , 261-265
Computed Tomography Observer Agreement in Staging Malignant Lymphoma
Objective To determine pretreatment computed tomography observer agreement in patients with newly diagnosed lymphoma. Methods Forty-nine computed tomography scans were reviewed by 3 experienced radiologists, with each scan assessed twice by 1 observer. Predefined nodal and extranodal regions were assessed, and Ann Arbor stages were assigned. K-statistics were defined as poor ( < 0.2), fair ( > 0.2 to 0.4), moderate ( > 0.4 to 0.6), substantial ( > 0.6 to 0.8), and almost perfect ( > 0.8 to 1). Results Nodal interobserver agreement varied from 0.09 for infraclavicular involvement to 0.95 for para-iliac involvement; intraobserver agreement was substantial to almost perfect, except for infraclavicular nodes. Extranodal interobserver agreement varied from 0.56 to 0.88; intraobserver agreement was substantial to almost perfect. Ann Arbor stage interobserver agreement varied from 0.57 to 0.69; intraobserver agreement was substantial. Conclusion Computed tomography observer agreement in staging malignant lymphoma appears to be suboptimal.
- 1 January 2016
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 40 (2) , 261-265
Computed Tomography Observer Agreement in Staging Malignant Lymphoma
Objective To determine pretreatment computed tomography observer agreement in patients with newly diagnosed lymphoma. Methods Forty-nine computed tomography scans were reviewed by 3 experienced radiologists, with each scan assessed twice by 1 observer. Predefined nodal and extranodal regions were assessed, and Ann Arbor stages were assigned. K-statistics were defined as poor ( < 0.2), fair ( > 0.2 to 0.4), moderate ( > 0.4 to 0.6), substantial ( > 0.6 to 0.8), and almost perfect ( > 0.8 to 1). Results Nodal interobserver agreement varied from 0.09 for infraclavicular involvement to 0.95 for para-iliac involvement; intraobserver agreement was substantial to almost perfect, except for infraclavicular nodes. Extranodal interobserver agreement varied from 0.56 to 0.88; intraobserver agreement was substantial to almost perfect. Ann Arbor stage interobserver agreement varied from 0.57 to 0.69; intraobserver agreement was substantial. Conclusion Computed tomography observer agreement in staging malignant lymphoma appears to be suboptimal.
- 25 April 2014
- Vol. 4 (3) , 231-8
Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.
The purpose of this study was to determine the correlation between the (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) standardized uptake value (SUV) and the diffusion-weighted magnetic resonance imaging (MRI) apparent diffusion coefficient (ADC) in newly diagnosed diffuse large B-cell lymphoma (DLBCL). Pretreatment FDG-PET and diffusion-weighted MRI of 21 patients with histologically proven DLBCL were prospectively analyzed. In each patient, maximum, mean and peak standardized uptake value (SUV) was measured in the lesion with visually highest FDG uptake and in the largest lesion. Mean ADC (ADCmean, calculated with b-values of 0 and 1000 s/mm(2)) was measured in the same lesions. Correlations between FDG-PET metrics (SUVmax, SUVmean, SUVpeak) and ADCmean were assessed using Pearson's correlation coefficients. In the lesions with visually highest FDG uptake, no significant correlations were found between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.498, P=0.609 and P=0.595, respectively). In the largest lesions, there were no significant correlations either between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.992, P=0.843 and P=0.894, respectively). The results of this study indicate that the glycolytic rate as measured by FDG-PET and changes in water compartmentalization and water diffusion as measured by the ADC are independent biological phenomena in newly diagnosed DLBCL. Further studies are warranted to assess the complementary roles of these different imaging biomarkers in the evaluation and follow-up of DLBCL.
- 25 April 2014
- Vol. 4 (3) , 231-8
Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.
The purpose of this study was to determine the correlation between the (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) standardized uptake value (SUV) and the diffusion-weighted magnetic resonance imaging (MRI) apparent diffusion coefficient (ADC) in newly diagnosed diffuse large B-cell lymphoma (DLBCL). Pretreatment FDG-PET and diffusion-weighted MRI of 21 patients with histologically proven DLBCL were prospectively analyzed. In each patient, maximum, mean and peak standardized uptake value (SUV) was measured in the lesion with visually highest FDG uptake and in the largest lesion. Mean ADC (ADCmean, calculated with b-values of 0 and 1000 s/mm(2)) was measured in the same lesions. Correlations between FDG-PET metrics (SUVmax, SUVmean, SUVpeak) and ADCmean were assessed using Pearson's correlation coefficients. In the lesions with visually highest FDG uptake, no significant correlations were found between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.498, P=0.609 and P=0.595, respectively). In the largest lesions, there were no significant correlations either between the SUVmax, SUVmean, SUVpeak and the ADCmean (P=0.992, P=0.843 and P=0.894, respectively). The results of this study indicate that the glycolytic rate as measured by FDG-PET and changes in water compartmentalization and water diffusion as measured by the ADC are independent biological phenomena in newly diagnosed DLBCL. Further studies are warranted to assess the complementary roles of these different imaging biomarkers in the evaluation and follow-up of DLBCL.